$ADNT

Adient plc

0
3
0

No SEC Form 4 filings for $ADNT in the last 30 days.

Med

Adient misses earnings estimates despite stronger-than-expected revenue

Adient (NYSE:ADNT) reported Q3 adjusted EPS of $0.48, below the $0.57 consensus, while revenue rose to $3.93B versus a $3.7B forecast. The company cited about $32M in temporary headwinds and operational inefficiencies. Adient kept FY2026 guidance, expecting ~$15B revenue, and reported GAAP net income of $25M. Shares were down ~0.9% premarket.

Adient reports third quarter financial results; reaffirms earnings and FCF outlook for FY26

Adient (NYSE: ADNT) reported Q3 2026 results: GAAP net income of $25M and diluted EPS of $0.32, versus adjusted diluted EPS of $0.48. Adjusted EBITDA was $225M, roughly flat year over year despite about $32M of temporary headwinds. At June 30, 2026, gross debt was ~$2.4B, net debt ~$1.5B, and cash ~$924M. The company said it generated free cash flow and repurchased $30M of shares in Q3.

Adient plc (ADNT): Results of Operations and Financial Condition

Adient plc (ADNT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a08052026adientexhibit991.htm EX-99.1 Document Exhibit 99.1 Appendix Page 1 Adient plc Condensed Consolidated Statements of Income (Loss) (Unaudited) Three Months Ended June 30, (in millions, except per share data) 2026 2025 Net sales $ 3,929 $ 3,741 Cost of sales 3,694

ADNT sentiment & insider activity

Over the past 7 days, alphai's AI scored 3 news stories mentioning ADNT (Adient plc). Coverage has been balanced: 0 bullish, 3 neutral, and 0 bearish.

Recent ADNT coverage spans earnings, financial news and insider activity.

What's driving ADNT

  • Mixed quarter results likely keep near-term sentiment pressured on earnings quality, despite revenue outperformance and unchanged FY outlook.

    yahoo.com · Aug 7, 2026

  • The release provides fresh quarterly datapoints plus reaffirmed FY26 outlook, supporting near-term positioning around earnings quality and FCF durability.

    prnewswire.com · Aug 5, 2026

  • Q2 operating and cash flow details (income statement, balance sheet, cash flow) provide a fresh baseline for near-term valuation and leverage expectations.

    SEC EDGAR 8-K · Aug 5, 2026

  • Board-level leadership transition risk and potential execution uncertainty until a new CFO is appointed.

    SEC EDGAR 8-K · Jul 10, 2026

  • Operational improvement in a cyclical auto supplier, paired with a deep valuation discount, frames a value/mean-reversion setup.

    livemint.com · Jun 16, 2026

alphai scores every news story that mentions ADNT with an AI model for sentiment and relevance, and aggregates insider trades from Adient plc's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $ADNT

Score
$ADNTMed

Adient misses earnings estimates despite stronger-than-expected revenue

Adient (NYSE:ADNT) reported Q3 adjusted EPS of $0.48, below the $0.57 consensus, while revenue rose to $3.93B versus a $3.7B forecast. The company cited about $32M in temporary headwinds and operational inefficiencies. Adient kept FY2026 guidance, expecting ~$15B revenue, and reported GAAP net income of $25M. Shares were down ~0.9% premarket.

$ADNTMedAI 8/10

Adient reports third quarter financial results; reaffirms earnings and FCF outlook for FY26

Adient (NYSE: ADNT) reported Q3 2026 results: GAAP net income of $25M and diluted EPS of $0.32, versus adjusted diluted EPS of $0.48. Adjusted EBITDA was $225M, roughly flat year over year despite about $32M of temporary headwinds. At June 30, 2026, gross debt was ~$2.4B, net debt ~$1.5B, and cash ~$924M. The company said it generated free cash flow and repurchased $30M of shares in Q3.

Adient plc (ADNT): Results of Operations and Financial Condition

Adient plc (ADNT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a08052026adientexhibit991.htm EX-99.1 Document Exhibit 99.1 Appendix Page 1 Adient plc Condensed Consolidated Statements of Income (Loss) (Unaudited) Three Months Ended June 30, (in millions, except per share data) 2026 2025 Net sales $ 3,929 $ 3,741 Cost of sales 3,694

$ADNTMed

Adient plc (ADNT): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Adient plc (ADNT) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. adnt-20260706 0001670541 FALSE 0001670541 2026-02-10 2026-02-10 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported):

$APHLow

Flawless Beats: 5 Stocks That Powered Through Q1 Earnings Volatility

The article says US Q1 2026 earnings stayed volatile but corporate results were strong: 827 US-listed stocks were projected to grow earnings 25.4% vs a 9.7% three-year average, and 54% of 721 reported companies beat estimates by 5%+. It highlights five names—Amphenol, Atlassian, Adient, Fair Isaac (FICO), and Rocket—citing Q1/Q2 revenue, EPS, cash flow, and discounts to fair value.

Adient plc (ADNT) Releases China Business Update

Adient plc (NYSE:ADNT) said in a May 20 China business update that since last year’s J.P. Morgan Summit it has received new bookings supporting sales growth. The company reported about $1.1 billion in annual business in FY2025 from four new auto brands, with ~70% from C-OEMs. It also noted a December 2025 JV via a 49% stake in SCI (Zhangjiakou) Co., Ltd.

12 Best Undervalued Stocks to Buy According to the Financial Media

Goldman Sachs Research raised its S&P 500 year-end 2026 forecast to 8,000 from 7,600 and expects a 6% return as of May 26. It increased 2026 EPS to $340 (24% growth) and 2027 EPS to $385 (13%). The valuation multiple for US stocks is projected near 21x. The article also lists 12 “undervalued” stocks based on forward P/E ~17x and Q1 2026 hedge-fund sentiment, including Adient (ADNT) with forward P/E ~10.7x and 27 holders.

$ADNTLow

JPMorgan Chase & Co. Sells 139,151 Shares of Adient $ADNT

JPMorgan Chase & Co. has reduced its stake in Adient (NYSE:ADNT) by selling 139,151 shares, now holding 1.63% of the company valued at approximately $31.86 million. Despite mixed analyst ratings with a consensus "Hold" and an average price target of $27.44, Adient recently surpassed earnings and revenue expectations. The article also highlights other institutional investment changes and Adient's financial performance, including its market capitalization, P/E ratio, and recent earnings per share.

Related tickers